GLP-1 (glucagon-like peptide 1): Research, Dosing, and Where to Buy in 2026
A research-first profile for GLP-1 (glucagon-like peptide 1) (GLP-1, glucagon-like peptide 1, GLP-1-like peptides), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
GLP-1 (glucagon-like peptide 1) is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, 26 transcript dosing protocols, and 2 referenced vendors for GLP-1 (glucagon-like peptide 1), each linked to its source.
- Also indexed as GLP-1, glucagon-like peptide 1, GLP-1-like peptides.
- 26 aggregated dosing-protocol mentions from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 2 vendor recommendations captured from named experts.
What is GLP-1 (glucagon-like peptide 1)?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
GLP-1 (glucagon-like peptide 1) Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
| Speaker | Source | Timestamp | Protocol | Evidence |
|---|---|---|---|---|
| Dr. Jones DC | 10 Tips BEFORE Starting GLP-1’s for Weight Loss (Doctor Explains) | 00:15:55 | According to Dr. Jones DC, the medication reset protocol involves: taper dose down step by step (often to zero), ~3 weeks at floor for receptor break, then restart at starter dose; restore calories to maintenance during the break while keeping protein and resistance training. | anecdotal |
| speakerA | What To Eat When Not Hungry #proteinintake #weightloss | 00:00:45 | speakerA anecdotally reported a protocol of tapering dose at some point and consuming goal-weight-in-grams of protein daily spread across the eating window, noting this approach helped maintain muscle mass during GLP-1 use. | anecdotal |
| Hunter | Reader Mailbag 4 - Peptide Overdoses, GLP-1 Anhedonia & Hormone Truths | 00:15:10 | Hunter discussed a peak/trough management approach using more frequent dosing rather than a single larger weekly shot, with the example of avoiding one weekly 8 mg retatrutide-style dose when side effects fluctuate. | anecdotal |
| Taylor | Reader Mailbag 4 - Peptide Overdoses, GLP-1 Anhedonia & Hormone Truths | 00:03:43 | Taylor described cycling off GLPs for 6 to 8 weeks, then slowly reintroducing to potentially reduce anhedonia effects, contrasting this approach with a shorter 4-week break. | anecdotal |
| speakerA | Scale Won't Move? It's This #metabolichealth #glp1 | 00:00:29 | speakerA reported consuming 1 g protein per pound of target body weight per day while on GLP-1, prioritizing protein at every meal even when not hungry | anecdotal |
| Dr. Jones DC | Most People Use GLP 1s WRONG: Here's What ACTUALLY Works (Ozempic,... | 00:14:21 | Some patients may taper down to a low-maintenance dose, a smaller group may eventually stop medication, and others may do best staying on long term. | anecdotal |
| Hunter | Saturday Morning Coffee Talk 6/6/26 | 01:33:28 | For athletes, Hunter reported using a microdose of 250-500 mcg per week and noted potential effects on inflammation and gut issues. | anecdotal |
| Vigorous Steve | BAM15 Vs. ATX-304, Cagrilintide Vs. Eloralintide, SLU-PP-915,... | 00:25:00 | According to Vigorous Steve, GLP-1 dosing comparisons generally range from 2-10 mg depending on tolerance and half-life. | anecdotal |
| Dr. Jones DC | Double Your GLP-1 Results Now | 00:21:38 | High-dose examples discussed as 10 mg tirzepatide or more, 4 mg retatrutide or more, or 1.5 mg semaglutide or more. | anecdotal |
| Dr. Jones DC | Even Smart People Make These Mistakes on GLP-1 (AVOID THESE) | 00:18:53 | Dr. Jones DC reported a microdose maintenance approach: clinically supervised GLP-1 doses well below standard titration and starting doses, administered indefinitely (potentially for life), with the reported intent to defend metabolic set point while rebuilding metabolic foundation. | anecdotal |
| Dr. Jones DC | 4 Rules for Lowering Your Dose #glp1 #weightloss | 00:00:01 | Standard protocol bumps dose every 4 weeks regardless. Rule 1: don't go down until stable for at least 4 weeks. Rule 2: use 'food chatter' (not the scale) as the signal - if you can get through a day without white-knuckling, the dose is still working. Rule 3: drop one level at a time, not two. Rule 4: only works with fasting, protein, and resistance training in place. Goal: lowest effective dose that keeps food chatter quiet. | anecdotal |
| Dr. Jones DC | The Biggest GLP-1 Myth #weightloss #tirzepatide | 00:00:54 | Reported strategy when stalled on GLP-1: users have described eating more strategically - with protein intake around 1 g per pound of target body weight, alongside resistance training to protect muscle, and sometimes adjusting the GLP-1 dose lower to allow appetite to return for fueling the body. Individual results and approaches vary. | anecdotal |
| Dr. Jones DC | Don't Switch Meds Yet #glp1 #weightloss | 00:00:49 | Speaker_1 reported that if GLP-1-related flatness or low motivation occurs, under medical supervision they would taper down, stop for three to four weeks, then restart the medication at a lower dose. The goal was using the lowest dose that still produced the desired effect. | anecdotal |
| Dr. Jones DC | Why Your GLP-1 Killed Your Drive #metabolichealth #hormonehealth | 00:01:11 | Some users and practitioners report that if experiencing motivational blunting ('dopamine void') on GLP-1, a first approach is dose reduction. If unresolved, some report tapering off completely for 3 to 4 weeks before restarting at a lower dose. | anecdotal |
| Dr. Jones DC | 5 Reasons GLP-1s Stall #metabolichealth #insulinresistance | 00:00:02 | Speaker1 reported using the lowest dose that quiets food noise rather than escalating to the highest tolerable dose. Their approach: avoid dose escalation every 4 weeks regardless of response-escalate only based on individual response. | anecdotal |
| Dr. Jones DC | The GLP-1 Side Effects They Didn't Mention | 00:00:39 | Dose adjustment is commonly reported by users as an approach to addressing over-suppression symptoms such as zero hunger, persistent nausea after week two, inability to eat 1200 calories, and loss of motivation. | anecdotal |
| Dr. Jones DC | Your Doctor's Dosing Strategy Is Backwards #glp1 #ozempic | 00:00:03 | Clinical-trial-style titration schedule described as fixed four-week dose increases to maximum dose; speaker argues this was copied into prescriptions but may not fit an individual patient. | anecdotal |
| Dr. Jones DC | Your GLP 1 Plateau Has A Name #metabolichealth #insulinresistance | 00:00:39 | A user reported experiencing persistent plateau after adjusting dose and diet, describing their approach as: medication reset, brief taper, then restart at a lower dose. | anecdotal |
| Dr. Jones DC | Easy Fix for Retatrutide Side Effects #glp1 #weightloss | 00:00:41 | Users have reported that if a GLP-1 dose is too strong to tolerate, skipping a week to allow it to clear and then restarting at half dose can help manage effects. | anecdotal |
| Dr. Jones DC | The 10 Best Foods That Make Ozempic & Zepbound Work FASTER! Weight... | 00:10:00 | Speaker proposes meal timing around GLP-1 dosing, including what to eat the day before injection, but does not provide the detailed protocol in this transcript. | anecdotal |
| The Peptide Podcast | Retatrutide, Hunger, and Food Noise | 00:10:14 | Some clinicians consider cycling strategies with weight-loss GLP-1s or adjunct approaches when response changes over time; no specific cycle given. | anecdotal |
| Dr. Jones DC | 10 Signs Your GLP-1 Dose is WRONG (common GLP-1 mistakes) | 00:14:08 | According to speaker_1 (anecdotal): A possible long-term approach involves a tiny maintenance dose (microdosing) or discontinuation if appropriate. | anecdotal |
| Dr. Jones DC | GLP-1 Users Who Keep It Off Do This #metabolichealth #insulinresistance | 00:00:45 | One user reported tapering to a micro dose during weight maintenance after GLP-1 therapy, describing it as a window to build metabolic habits. | anecdotal |
| The Hunter Williams Podcast | Saturday Morning Coffee Talk 6/20/26 | 00:12:49 | Speaker suggests a microdose GLP could help inflammation/period issues indirectly; no exact dose given. | anecdotal |
| Dr. Jones DC | Doctor Explains How to Make GLPs 10x More Effective | 00:16:28 | Maintenance may mean no medication for some people or a small microdosed maintenance dose for others. | anecdotal |
| The Peptide Podcast | GLP-1 Microdosing | 00:01:13 | Microdosing GLP-1 agonists is described as taking very small sub-therapeutic doses, much lower than diabetes or obesity treatment doses. | anecdotal |
Where to Buy GLP-1 (glucagon-like peptide 1) in 2026
APR Health Solutions
Code: NYLE (per Nyle's podcast affiliate)Visit vendor → View profile →Recommended by Promo voice at 00:24:58.
Optimize HRT
Code: NYLEVisit vendor → View profile →Recommended by Host at 01:53:51.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about GLP-1 (glucagon-like peptide 1). Each line links to the original source.
- "These new antiobesity medications can reach up to 24% weight loss, which makes possible an effective management of obesity and its complications." · Salvador J et al, 2025 PubMed
- "Between 60 and 75% of people regain weight after stopping a GLP-1." · speaker_1 on "GLP-1 Users Who Keep It Off Do This #metabolichealth #insuli" @ 0:02
- "A speaker reported that most people regain weight after discontinuing GLP-1 medications, with approximately 60 to 75% of lost weight returning (source: cw7m4tuVSRo)." · speaker on "They Kept It Off. Here's How #glp1 #weightregain" @ 0:04
- "Up to 40% of what you lose on GLP-1s can come from muscle tissue, not fat." · speaker_1 on "Doctor Explains How to Make GLPs 10x More Effective" @ 3:29
- "And in some studies, it climbs towards 40%." · Dr. Jones DC on "Even Smart People Make These Mistakes on GLP-1 (AVOID THESE)" @ 4:28
- "In DEXA sub studies, roughly 25 to 40% of the weight lost on these drugs was lean body mass, was muscle mass, with the majority still being fat." · Dr. Jones DC on "Most People Use GLP 1s WRONG: Here's What ACTUALLY Works (Oz" @ 7:51
Research and Studies
8 PubMed-indexed papers reference GLP-1 (glucagon-like peptide 1). Top 8 shown.
Legal Status
GLP-1 (glucagon-like peptide 1) is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is GLP-1 (glucagon-like peptide 1) FDA-approved?
GLP-1 (glucagon-like peptide 1) is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
What dosing is reported for GLP-1 (glucagon-like peptide 1)?
This page aggregates 26 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.
Where can I buy GLP-1 (glucagon-like peptide 1)?
2 vendor recommendation(s) are tracked in our directory, sourced from named-expert mentions. See the Where to Buy section above. Always verify COA and current regulatory status.
How much research has been published on GLP-1 (glucagon-like peptide 1)?
8 PubMed-indexed paper(s) reference GLP-1 (glucagon-like peptide 1) in our current research feed. See the Research and Studies section above for citations.